risedronic acid has been researched along with genistein in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, S; Boris, ME; Jackson, GS; Martin, BR; McCabe, GP; McCabe, LD; Nolan, JR; Peacock, M; Reinwald, S; Weaver, CM | 1 |
| Barnes, S; Jackson, GS; Martin, BR; McCabe, GP; McCabe, L; Pawlowski, JW; Peacock, M; Weaver, CM | 1 |
2 trial(s) available for risedronic acid and genistein
| Article | Year |
|---|---|
Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using (41)Ca methodology.
Topics: Aged; Analysis of Variance; Bone Density Conservation Agents; Bone Resorption; Calcium; Calcium Radioisotopes; Cotyledon; Cross-Over Studies; Dietary Supplements; Estradiol; Etidronic Acid; Female; Genistein; Glycine max; Humans; Isoflavones; Linear Models; Medroxyprogesterone; Middle Aged; Osteoporosis, Postmenopausal; Phytoestrogens; Plant Preparations; Pueraria; Risedronic Acid; Single-Blind Method; Treatment Outcome; Trifolium | 2009 |
Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trial.
Topics: Administration, Oral; Aged; Bone and Bones; Calcium; Cross-Over Studies; Dietary Supplements; Dose-Response Relationship, Drug; Equol; Female; Genistein; Glycine max; Humans; Isoflavones; Middle Aged; Osteoporosis, Postmenopausal; Phytoestrogens; Postmenopause; Risedronic Acid | 2015 |